182 related articles for article (PubMed ID: 37435091)
1. Myasthenia Gravis Exacerbation Following Immunization With the BNT162b2 mRNA COVID-19 Vaccine: Report of a Case and Review of the Literature.
Papadopoulou M; Stefanou MI; Palaiodimou L; Tsivgoulis G
Neurohospitalist; 2023 Jul; 13(3):303-307. PubMed ID: 37435091
[TBL] [Abstract][Full Text] [Related]
2. BNT162b2 mRNA COVID-19 vaccine three-dose safety and risk of COVID-19 in patients with myasthenia gravis during the alpha, delta, and omicron waves.
Doron A; Piura Y; Vigiser I; Kolb H; Regev K; Nesher N; Karni A
J Neurol; 2022 Dec; 269(12):6193-6201. PubMed ID: 35907046
[TBL] [Abstract][Full Text] [Related]
3. Myasthenia gravis exacerbation and myasthenic crisis associated with COVID-19: case series and literature review.
Rodrigues CL; de Freitas HC; Lima PRO; de Oliveira Junior PH; Fernandes JMA; D'Almeida JAC; Nóbrega PR
Neurol Sci; 2022 Apr; 43(4):2271-2276. PubMed ID: 35039987
[TBL] [Abstract][Full Text] [Related]
4. Safety and tolerability of SARS-Cov-2 vaccination in patients with myasthenia gravis: A multicenter experience.
Farina A; Falso S; Cornacchini S; Spagni G; Monte G; Mariottini A; Massacesi L; Barilaro A; Evoli A; Damato V
Eur J Neurol; 2022 Aug; 29(8):2505-2510. PubMed ID: 35390184
[TBL] [Abstract][Full Text] [Related]
5. Safety of mRNA COVID-19 vaccines in patients with well-controlled myasthenia gravis.
Gamez J; Gamez A; Carmona F
Muscle Nerve; 2022 Nov; 66(5):612-617. PubMed ID: 36029224
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune myasthenia gravis after COVID-19 in a triple vaccinated patient.
Croitoru CG; Cuciureanu DI; Prutianu I; Cianga P
Arch Clin Cases; 2022; 9(3):104-107. PubMed ID: 36176496
[TBL] [Abstract][Full Text] [Related]
7. An Interesting Case of Fatal Myasthenic Crisis Probably Induced by the COVID-19 Vaccine.
Sonigra KJ; Sarna K; Vaghela VP; Guthua S
Cureus; 2022 Mar; 14(3):e23251. PubMed ID: 35449619
[TBL] [Abstract][Full Text] [Related]
8. Vaccines and myasthenia gravis: a comprehensive review and retrospective study of SARS-CoV-2 vaccination in a large cohort of myasthenic patients.
Sansone G; Bonifati DM
J Neurol; 2022 Aug; 269(8):3965-3981. PubMed ID: 35503373
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 Vaccination and Late-Onset Myasthenia Gravis: A New Case Report and Review of the Literature.
Virgilio E; Tondo G; Montabone C; Comi C
Int J Environ Res Public Health; 2022 Dec; 20(1):. PubMed ID: 36612789
[TBL] [Abstract][Full Text] [Related]
10. MOG encephalomyelitis after vaccination against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2): case report and comprehensive review of the literature.
Jarius S; Bieber N; Haas J; Wildemann B
J Neurol; 2022 Oct; 269(10):5198-5212. PubMed ID: 35737110
[TBL] [Abstract][Full Text] [Related]
11. Early Flare-Ups of Myasthenia Gravis After Thoracoscopic Thymectomy in a Patient Recently Receiving BNT162b2 mRNA COVID-19 Vaccination.
Dharmasaroja P
Cureus; 2022 Jan; 14(1):e21571. PubMed ID: 35228930
[TBL] [Abstract][Full Text] [Related]
12. New-onset myasthenia gravis after mRNA SARS-CoV-2 vaccination: a case series.
Fanella G; Baiata C; Candeloro E; Toscano G; Colnaghi S; Mauri M; Cariddi LP; Rebecchi V; Solazzo F; Banfi P; Piatti M; Ferrarese C; Versino M
Neurol Sci; 2022 Oct; 43(10):5799-5802. PubMed ID: 35870026
[TBL] [Abstract][Full Text] [Related]
13. Coincidental Onset of Ocular Myasthenia Gravis Following ChAdOx1 n-CoV-19 Vaccine against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Galassi G; Rispoli V; Iori E; Ariatti A; Marchioni A
Isr Med Assoc J; 2022 Jan; 24(1):9-10. PubMed ID: 35077038
[TBL] [Abstract][Full Text] [Related]
14. A Case of COVID-19 Vaccine Associated New Diagnosis Myasthenia Gravis.
Chavez A; Pougnier C
J Prim Care Community Health; 2021; 12():21501327211051933. PubMed ID: 34709075
[TBL] [Abstract][Full Text] [Related]
15. Bullous pemphigoid after second dose of mRNA- (Pfizer-BioNTech) Covid-19 vaccine: A case report.
Alshammari F; Abuzied Y; Korairi A; Alajlan M; Alzomia M; AlSheef M
Ann Med Surg (Lond); 2022 Mar; 75():103420. PubMed ID: 35251600
[TBL] [Abstract][Full Text] [Related]
16. Generalized Papulovesicular Eruption as a Side Effect of the Pfizer-BioNTech COVID-19 Vaccine.
Alamri A; Alghamdi Y; Alamri SJ; Althaqafi MK; AlQurashi W; Bader BA; Mohanna AT; Almahdi B
Cureus; 2022 Feb; 14(2):e22414. PubMed ID: 35371700
[TBL] [Abstract][Full Text] [Related]
17. Myasthenia Gravis Presenting after Administration of the mRNA-1273 Vaccine.
Hoshina Y; Sowers C; Baker V
Eur J Case Rep Intern Med; 2022; 9(7):003439. PubMed ID: 36051160
[TBL] [Abstract][Full Text] [Related]
18. Immune-Mediated Thrombotic Thrombocytopenic Purpura Following mRNA-Based COVID-19 Vaccine BNT162b2: Case Report and Mini-Review of the Literature.
Buetler VA; Agbariah N; Schild DP; Liechti FD; Wieland A; Andina N; Hammann F; Kremer Hovinga JA
Front Med (Lausanne); 2022; 9():890661. PubMed ID: 35655852
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy-induced myasthenic crisis in thymoma treated with primary chemotherapy with curative intent on mechanical ventilation: a case report and review of the literature.
Patelli G; Bencardino K; Tosi F; Pugliano M; Lanzani F; Innocenti A; Rinaldo A; Mauri G; Cerea G; Sartore-Bianchi A; Torre M; Agostoni EC; Siena S
J Med Case Rep; 2021 Feb; 15(1):32. PubMed ID: 33526108
[TBL] [Abstract][Full Text] [Related]
20. Protection from previous natural infection compared with mRNA vaccination against SARS-CoV-2 infection and severe COVID-19 in Qatar: a retrospective cohort study.
Chemaitelly H; Ayoub HH; AlMukdad S; Coyle P; Tang P; Yassine HM; Al-Khatib HA; Smatti MK; Hasan MR; Al-Kanaani Z; Al-Kuwari E; Jeremijenko A; Kaleeckal AH; Latif AN; Shaik RM; Abdul-Rahim HF; Nasrallah GK; Al-Kuwari MG; Butt AA; Al-Romaihi HE; Al-Thani MH; Al-Khal A; Bertollini R; Abu-Raddad LJ
Lancet Microbe; 2022 Dec; 3(12):e944-e955. PubMed ID: 36375482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]